|
|
|
Insider
Information: |
Dp Vii Associates Lp |
Relationship: |
10% Owner |
City: |
Princeton |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
413,446 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$6,967,132 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
413,446 |
|
|
Total
Value |
$6,967,132 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Orexigen Therapeutics, Inc. |
OREX |
10% Owner |
2011-12-22 |
50,643 |
2008-12-09 |
0 |
Premium* |
|
Cadence Pharmaceuticals Inc |
CADX |
10% Owner |
2014-03-19 |
0 |
|
0 |
Premium* |
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2011-09-16 |
169,251 |
2010-11-29 |
0 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2011-11-21 |
51,013 |
2011-11-21 |
0 |
Premium* |
|
Esperion Therapeutics, Inc. |
ESPR |
10% Owner |
2013-07-01 |
35,253 |
2013-07-01 |
0 |
Premium* |
|
Evoke Pharma Inc |
EVOK |
10% Owner |
2013-09-30 |
19,006 |
2013-09-30 |
0 |
Premium* |
|
Tandem Diabetes Care Inc |
TNDM |
10% Owner |
2013-11-19 |
54,390 |
2013-11-19 |
0 |
Premium* |
|
Achaogen Inc |
AKAO |
10% Owner |
2014-03-17 |
33,890 |
2014-03-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
29 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AKAO |
Achaogen Inc |
10% Owner |
|
2014-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
33,890 |
33,890 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2009-02-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
46,634 |
|
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2014-03-19 |
4 |
D |
$14.00 |
$710,402 |
D/D |
(50,743) |
0 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
10% Owner |
|
2011-11-21 |
4 |
B |
$13.00 |
$203,125 |
D/D |
15,625 |
51,013 |
2.45 |
- |
|
CLVS |
Clovis Oncology, Inc. |
10% Owner |
|
2011-11-21 |
4 |
A |
$0.00 |
$0 |
D/D |
35,388 |
35,388 |
0 |
- |
|
ESPR |
Esperion Therapeutics, In... |
10% Owner |
|
2013-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,462 |
30,462 |
0 |
- |
|
ESPR |
Esperion Therapeutics, In... |
10% Owner |
|
2013-07-01 |
4 |
B |
$14.00 |
$67,074 |
D/D |
4,791 |
35,253 |
2.45 |
- |
|
EVOK |
Evoke Pharma Inc |
10% Owner |
|
2013-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
19,006 |
19,006 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2008-12-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,173 |
|
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2008-12-09 |
4 |
B |
$4.93 |
$20,036 |
D/D |
4,064 |
8,237 |
2.37 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-07-23 |
4 |
B |
$7.50 |
$81,758 |
D/D |
10,901 |
19,138 |
2.45 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-08-11 |
4 |
B |
$7.60 |
$13,292 |
D/D |
1,749 |
20,887 |
2.37 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-08-12 |
4 |
B |
$8.00 |
$53,664 |
D/D |
6,708 |
27,595 |
2.45 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-08-13 |
4 |
B |
$7.85 |
$1,711 |
D/D |
218 |
27,813 |
2.37 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-08-14 |
4 |
B |
$8.00 |
$3,520 |
D/D |
440 |
28,253 |
2.37 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-08-17 |
4 |
B |
$7.64 |
$8,098 |
D/D |
1,060 |
29,313 |
2.37 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-10 |
4 |
B |
$6.93 |
$9,806 |
D/D |
1,415 |
30,959 |
2.37 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-11 |
4 |
B |
$6.93 |
$6,230 |
D/D |
899 |
31,858 |
2.37 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-12 |
4 |
B |
$6.90 |
$7,176 |
D/D |
1,040 |
32,898 |
2.37 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-20 |
4 |
B |
$6.93 |
$29,051 |
D/D |
4,192 |
37,090 |
2.37 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-23 |
4 |
B |
$6.93 |
$17,436 |
D/D |
2,516 |
39,606 |
2.37 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-24 |
4 |
B |
$6.75 |
$5,663 |
D/D |
839 |
40,445 |
2.37 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-12-17 |
4 |
B |
$7.55 |
$12,661 |
D/D |
1,677 |
42,122 |
2.37 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-12-18 |
4 |
B |
$7.50 |
$4,793 |
D/D |
639 |
42,761 |
2.37 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2011-12-22 |
4 |
B |
$1.45 |
$11,429 |
D/D |
7,882 |
50,643 |
2.37 |
- |
|
29 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|